Article
Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity.
Stroke - 1 Jan 2020
Mo Jinglin, Chen Zimo, Xu Jie, Wang Anxin, Dai Liye, Cheng Aichun, Meng Xia, Li Hao, Wang Yongjun
Abstract excerpt
Background and Purpose- The role of dual-antiplatelet therapy with clopidogrel plus aspirin has been demonstrated to substantially decrease the risk of recurrent stroke among patients with minor stroke and transient ischemic attack. We aimed to determine whether the efficacy of clopidogrel-aspirin therapy among patients with minor stroke / transient ischemic attack was influenced by the stratification of CYP2C19...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.